FDA approves GSK's bepirovirsen for chronic hepatitis B after a 19% functional cure rate, raising oligonucleotide scale-up stakes for manufacturers.
News|Articles|January 1, 2002
- Pharmaceutical Technology-01-02-2002
- Volume 26
- Issue 1
What Does Pharmacy Automation Mean for Packaging?
Author(s)Hallie Forcinio
A limited number of container sizes, dispensing lanes, computerized tracking, and polyethylene mailing bags are just a few of the new elements of packaging launched at one company's automated pharmacy facility.
Advertisement
Articles in this issue
almost 25 years ago
Novel Acrylate Adhesives for Transdermal Drug Deliveryalmost 25 years ago
Optimal Tablet Press Operation: Machine versus Granulationalmost 25 years ago
Manufacturers Face Shifting Priorities in the New Yearalmost 25 years ago
Investigation of Out-of-Specification Resultsalmost 25 years ago
Reaping the Benefits of E-Procurementalmost 25 years ago
Outsourcing OutlookAdvertisement
Related to this article
Ravi Kiran Kaja, PhD, USP, explains what harmonization of extractables and leachables standards looks like in practice.
Nine duloxetine recalls since 2024 show why generic drug manufacturers need route-level nitrosamine risk assessment, not end-product testing alone.
Ravi Kiran Kaja, PhD, explains how USP’s industry-wide initiative aims to build confidence in trace-level extractables and leachables results.
Science, circularity, regulation, and technology are reshaping how the industry develops packaging for medicines.
AI accountability, faster FDA pathways, rare disease CMC review, and next-gen GLP-1 formulation lead this week’s PharmTech roundup.
MASH and cardiomyopathy AI collaboration: AstraZeneca pays insitro $40M upfront for target discovery, then leads clinical development and CMC planning.
Nate Edwards of Arya Consulting moderates a discussion with Elisabeth Gardiner of Tevard Biosciences and Donny Xu of the RTW Institute about rare disease treatment development and navigating the FDA’s Rare Pediatric Disease Priority Review Voucher Program.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
OpenAI Bets on Accelerating Drug Development Timelines With Orchestra Bio
2
Nitrosamine Problems and Industry Solutions: PharmTech Explained
3
AAPS PharmSci 360 2026: System Suitability Standards in E&L Testing
4
FDA Approves Bepirovirsen: Why Oligonucleotide CDMOs Should Take Note
5